Further support for differential brain mechanisms underlying chronic visceral pain comes from a recent PET ligand study which showed differences in neurokinin-1 receptor (NK-1R) binding potential (e.g. receptor availability) between patients with IBD (including Crohn's disease and UC) and IBS subjects [60]. This evidence concerns the gene TACR1 and inflammatory bowel disease.